A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)

Peer Review reports

Original Submission
22 Jul 2019	Submitted	Original manuscript
25 Aug 2019	Author responded	Author comments - Carole Mercier
Resubmission - Version 2
25 Aug 2019	Submitted	Manuscript version 2
Publishing
26 Aug 2019	Editorially accepted
4 Sep 2019	Article published	10.1186/s12885-019-6097-z

Back to article page